AUTHOR=Powell Danielle S. , Kuo Pei-Lun , Qureshi Riaz , Coburn Sally B. , Knopman David S. , Palta Priya , Gottesman Rebecca , Griswold Michael , Albert Marilyn , Deal Jennifer A. , Gross Alden L. 

TITLE=The Relationship of APOE ε4, Race, and Sex on the Age of Onset and Risk of Dementia

JOURNAL=Frontiers in Neurology

VOLUME=12

YEAR=2021

URL=https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2021.735036

DOI=10.3389/fneur.2021.735036

ISSN=1664-2295

ABSTRACT=<p><bold>Objective:</bold> To investigate whether <italic>APOE</italic> ε4 genotype—an established risk factor for dementia—is associated with earlier age at diagnosis in addition to increased risk overall and in secondary analysis by race and sex.</p><p><bold>Methods:</bold> We followed up 13,782 dementia-free individuals (<italic>n</italic> = 10,137 White, <italic>n</italic> = 3,645 Black, baseline age 60–66 years) in the Atherosclerosis Risk in Communities study for up to 30 years. Dementia was operationalized using standardized algorithms incorporating longitudinal cognitive change, proxy report, and hospital or death certificate dementia codes. We used a mixture of generalized gamma distributions to simultaneously estimate time to dementia, time to dementia-free death, and the proportion of individuals with dementia, by <italic>APOE</italic> ε4 status (≥1 vs. no alleles).</p><p><bold>Results:</bold> Median age of dementia onset among <italic>APOE</italic> ε4 carriers was 81.7 (Blacks) and 83.3 years (Whites) compared with 82.6 (Blacks) and 85.7 years (Whites) in non-<italic>APOE</italic> ε4 carriers (<italic>p</italic> &gt; 0.05 Blacks; <italic>p</italic> &lt; 0.01 Whites). Age of dementia diagnosis did not differ by sex in ε4 carriers, but among non-carriers, average age was earlier in males than females regardless of race. <italic>APOE</italic> ε4 carriers had on average a higher proportion of diagnoses; results did not differ by race or sex.</p><p><bold>Conclusions:</bold><italic>APOE</italic> ε4 carrier status is associated with earlier age of dementia diagnosis with differences across race and sex. These findings clarify the causal role of <italic>APOE</italic> in dementia etiology, which could help better identify at-risk subgroups and may help facilitate better research trial recruitment and design.</p>